title: Detection of glaucoma in a cohort of chinese subjects with systemic hypertension.
abstract: Purpose. To determine the presence and type of glaucoma in a cohort of adult Chinese subjects with systemic hypertension. Methods. This prospective cohort study included 200 hypertensive Chinese adults aged >40 years old who underwent screening via frequency doubling technology (FDT) perimetry and intraocular pressure (IOP) measurement by noncontact tonometry (NCT) in a general outpatient clinic. Those with IOP > 21 mmHg and/or visual field (VF) defects on FDT were referred for complete ophthalmological examination. The diagnosis of glaucoma was based on an abnormal VF on Humphrey Field Analyzer (HFA) by Hodapp-Parrish-Anderson's criteria and an increased vertical cup-disc ratio (VCDR). Results. The mean age of the subjects was 64.66 ± 9.47 years, and the male:female ratio was 92 : 108. All patients were hypertensive with a mean blood pressure (BP) of 131.1 ± 15.1/76.6 ± 11.1 mmHg whilst on systemic antihypertensive medication. Of the 111 patients that had an abnormal initial screening, 14 (7.9%) were confirmed to have glaucoma with the highest prevalence of normal tension glaucoma (NTG) (6.2%), followed by primary angle closure glaucoma (PACG) (1.1%) and primary open angle glaucoma (POAG) (0.5%). The positive predictive value of FDT perimetry was 71%. Conclusion. Nearly 8% of the adults with systemic hypertension had glaucoma, and NTG was the most prevalent type.
authors: Department of Ophthalmology, The University of Hong Kong, Hong Kong.
authors: Rita A
authors: RA
authors: Gangwani
authors: Jonathan
authors: J
authors: Chan
authors: Jacky
authors: J
authors: Lee
authors: Alfred
authors: A
authors: Kwong
authors: Jimmy S M
authors: JS
authors: Lai
references: Ophthalmology. 1991 Jan;98(1):70-5
references: 2023736
references: Invest Ophthalmol Vis Sci. 1997 Feb;38(2):413-25
references: 9040475
references: Am J Ophthalmol. 2011 Jun;151(6):1057-1064.e1
references: 21470593
references: J Glaucoma. 2004 Aug;13(4):319-26
references: 15226661
references: Am J Ophthalmol. 2001 Jun;131(6):699-708
references: 11384564
references: J Glaucoma. 1996 Oct;5(5):308-10
references: 8897229
references: Graefes Arch Clin Exp Ophthalmol. 1991;229(6):501-4
references: 1765286
references: Curr Eye Res. 2007 Feb;32(2):153-60
references: 17364748
references: Arch Ophthalmol. 1989 Jan;107(1):81-6
references: 2642703
references: Arch Ophthalmol. 2007 Jun;125(6):805-12
references: 17562992
references: Clin Exp Ophthalmol. 2011 Apr;39(3):252-8
references: 20973906
references: Br J Ophthalmol. 2009 Oct;93(10):1276-82
references: 19336425
references: Ophthalmology. 2004 Sep;111(9):1641-8
references: 15350316
references: Am J Ophthalmol. 2000 Mar;129(3):314-22
references: 10704546
references: Am J Ophthalmol. 1998 Feb;125(2):242-4
references: 9467452
references: Arch Ophthalmol. 1995 Feb;113(2):216-21
references: 7864755
references: Ophthalmology. 2009 Dec;116(12):2373-80
references: 19815279
references: Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2782-8
references: 16799014
references: Am J Ophthalmol. 1994 May 15;117(5):603-24
references: 8172267
references: Ophthalmology. 2011 Jun;118(6):1024-30
references: 21269703
references: Arch Ophthalmol. 1973 Jun;89(6):457-65
references: 4706442
references: Br J Ophthalmol. 1981 Jan;65(1):56-62
references: 7448157
references: Clin Exp Optom. 2011 Mar;94(2):133-49
references: 21255075
references: Ophthalmology. 2008 Jan;115(1):85-93
references: 17629563
references: Arch Ophthalmol. 2001 Dec;119(12):1819-26
references: 11735794
references: Invest Ophthalmol Vis Sci. 1994 Jan;35(1):268-80
references: 8300355
references: Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2451-7
references: 15980235
references: Arch Ophthalmol. 1996 Jan;114(1):19-22
references: 8540846